DK0581797T3 - Hidtil ukendte thiophen-2-carboxylsyrederivater og fremgangsmåde til deres fremstillng - Google Patents

Hidtil ukendte thiophen-2-carboxylsyrederivater og fremgangsmåde til deres fremstillng

Info

Publication number
DK0581797T3
DK0581797T3 DK92908327.7T DK92908327T DK0581797T3 DK 0581797 T3 DK0581797 T3 DK 0581797T3 DK 92908327 T DK92908327 T DK 92908327T DK 0581797 T3 DK0581797 T3 DK 0581797T3
Authority
DK
Denmark
Prior art keywords
preparation
processes
carboxylic acid
acid derivatives
new thiophene
Prior art date
Application number
DK92908327.7T
Other languages
English (en)
Inventor
Dieter Binder
Gerhard Greier
Original Assignee
Laevosan Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laevosan Gmbh & Co Kg filed Critical Laevosan Gmbh & Co Kg
Application granted granted Critical
Publication of DK0581797T3 publication Critical patent/DK0581797T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Indicating Or Recording The Presence, Absence, Or Direction Of Movement (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK92908327.7T 1991-04-04 1992-04-01 Hidtil ukendte thiophen-2-carboxylsyrederivater og fremgangsmåde til deres fremstillng DK0581797T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0071691A AT395425B (de) 1991-04-04 1991-04-04 Neue thiophen-2-carbonsaeurederivate und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
DK0581797T3 true DK0581797T3 (da) 1998-02-02

Family

ID=3497929

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92908327.7T DK0581797T3 (da) 1991-04-04 1992-04-01 Hidtil ukendte thiophen-2-carboxylsyrederivater og fremgangsmåde til deres fremstillng

Country Status (15)

Country Link
US (1) US5352692A (da)
EP (2) EP0507763A1 (da)
JP (1) JPH06506208A (da)
AT (2) AT395425B (da)
AU (1) AU656772B2 (da)
CA (1) CA2107662A1 (da)
CZ (1) CZ280202B6 (da)
DE (1) DE59208727D1 (da)
DK (1) DK0581797T3 (da)
ES (1) ES2104908T3 (da)
FI (1) FI934184A0 (da)
GR (1) GR3024594T3 (da)
HU (1) HUT68476A (da)
SK (1) SK106093A3 (da)
WO (1) WO1992017472A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0891343A1 (en) * 1996-04-03 1999-01-20 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US8208300B2 (en) * 2008-01-08 2012-06-26 Spansion Israel Ltd Non-volatile memory cell with injector

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2126597A1 (de) * 1971-05-28 1972-12-14 Farbwerke Hoechst AG, vormals, Meister Lucius & Brüning, 6000 Frankfurt Aminothiophencarbonsäureester und Verfahren zu ihrer Herstellung
GB2065121A (en) * 1979-12-13 1981-06-24 Pfizer Ltd Isoquinoline Derivatives
AT376436B (de) * 1982-11-05 1984-11-26 Laevosan Gmbh & Co Kg Verfahren zur herstellung neuer thiophen-2carbons[urederivate und pharmazeutisch vertraeglicher saeure- oder basenadditionssalze davon

Also Published As

Publication number Publication date
CA2107662A1 (en) 1992-10-05
FI934184A (fi) 1993-09-24
FI934184A0 (fi) 1993-09-24
HU9302786D0 (en) 1993-12-28
HUT68476A (en) 1995-06-28
ATE155783T1 (de) 1997-08-15
SK106093A3 (en) 1994-08-10
GR3024594T3 (en) 1997-12-31
EP0581797A1 (de) 1994-02-09
EP0581797B1 (de) 1997-07-23
ATA71691A (de) 1992-05-15
AT395425B (de) 1992-12-28
EP0507763A1 (de) 1992-10-07
US5352692A (en) 1994-10-04
CZ9302002A3 (en) 1994-07-13
WO1992017472A1 (de) 1992-10-15
AU1640292A (en) 1992-11-02
JPH06506208A (ja) 1994-07-14
DE59208727D1 (de) 1997-09-04
AU656772B2 (en) 1995-02-16
ES2104908T3 (es) 1997-10-16
CZ280202B6 (cs) 1995-11-15

Similar Documents

Publication Publication Date Title
DK0650961T3 (da) Substituerede heterocykliske carboxylsyreamider, deres fremstilling og deres anvendelse som lægemidler.
DE69420068T2 (de) 1H-Indol-3-Acetamid-Derivate als sPLA2-Inhibitoren
BR9401484A (pt) Hidrazida de ácido 1h-indol-3-acético e formulação farmacêutica
NO920320D0 (no) Bifenylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
HU910874D0 (en) 1,4,7,10-tetraaza-cyclododecane-butyl-thiol derivatives, process for producing these compounds and pharmaceutical preapratives containing them
DK469589A (da) 7-substituerede derivater af 3,5-dihydroxyhept-6-ynsyre, deres fremstilling og anvendelse samt ved fremstillingen anvendelige mellemprodukter
DK0594099T3 (da) Fremgangsmåde til rensning af rå clavulansyre
DK0581797T3 (da) Hidtil ukendte thiophen-2-carboxylsyrederivater og fremgangsmåde til deres fremstillng
DK0571243T3 (da) Thiochromanderivater, fremgangsmåder til fremstilling heraf samt farmaceutiske midler indeholdende d isse
ES8304971A1 (es) Un procedimiento para la preparacion de derivados de tiocarbapenem 3-sustituidos.
NO883486L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
AU622590B2 (en) Lowering of blood uric acid levels
DE69406382D1 (de) Verfahren zur Herstellung von N-Phenyl-N-(4-Piperidinyl)Amid-Derivaten
ES2020145A6 (es) Procedimiento de obtencion de esteres del acido 2-(2,6-diclorofenil)amino) fenilacetoxiacetico.
ES2108894T3 (es) Procedimiento para la preparacion de 5-cloroimidazoles eventualmente sustituidos en posicion 2.
DK0429751T3 (da) Substituerede 3-aminosydnoniminer, fremgangsmåde til deres fremstilling og deres anvendelse
ES2046141A1 (es) "procedimiento para la obtencion del acido 2-((2,6-diclorofenil)amino) fenilacetoxiacetico"
ATE200282T1 (de) Herstellung eines epoxids
ES2007236A6 (es) Procedimiento para la sintesis de n-(beta-hidroxietil) dl-2-(4'-isobutilfenil)propionamida.